Polymer prodrug approaches applied to paclitaxel
- 3 February 2010
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 1 (6) , 778-792
Abstract
Paclitaxel possesses a unique mechanism of drug action as a new class of microtubule stabilizing agent which finally leads to disrupted mitosis and cell death. Recent findings have shown that paclitaxel initiates apoptosis through multiple mechanisms. However, the strong hydrophobicity of paclitaxel drastically limits its use in natural form. In addition, significant toxicity which is mainly ascribed to the non-specific, indiscriminate distribution among the tissues limited the application of paclitaxel in cancer therapy. Therefore, it remains of interest to improve their use by enhancing solubility, selectivity and in vivo delivery by preparing functional prodrugs selectively activable in tumour areas. This article summarizes results and information derived recently from paclitaxel prodrugs based mainly on macromolecular conjugates and their interactions with body fluids. We also explore the potential application of site-specific carriers in the development of tumor-targeting paclitaxel conjugates.Keywords
This publication has 129 references indexed in Scilit:
- Oil-Encapsulating PEO−PPO−PEO/PEG Shell Cross-Linked Nanocapsules for Target-Specific Delivery of PaclitaxelBiomacromolecules, 2007
- Paclitaxel-Warfarin Interaction in SolutionMacromolecular Symposia, 2006
- Development of first photoresponsive prodrug of paclitaxelBioorganic & Medicinal Chemistry Letters, 2006
- Properties of a Water-Soluble Paclitaxel Conjugate in Aqueous Solution and its Interaction with Serum AlbuminMacromolecular Symposia, 2005
- Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugateBiomaterials, 2005
- Self-Diffusion of PEO-Modified Paclitaxel in Aqueous Solution: Hydrodynamic PropertiesMacromolecular Symposia, 2004
- Nanocoatings onto Arteries via Layer-by-Layer Deposition: Toward the in Vivo Repair of Damaged Blood VesselsJournal of the American Chemical Society, 2003
- Cremophor ELEuropean Journal of Cancer, 2001
- Weekly paclitaxel in advanced non[ndash ]small cell lung cancerSeminars in Oncology, 2001
- Drug delivery systems using hyaluronan and its derivativesAdvanced Drug Delivery Reviews, 1991